Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Expert views
PolyPeptide supports landmark publication on sustainable peptide synthesis
23 Oct 2024 - PolyPeptide’s experts Jan Pawlas and Jon Holbech Rasmussen contributed to the recent landmark publication by UK’s Royal Society of Chemistry: “Sustainability in Tides Chemistry: Green Approaches […]
Read moreBusiness news
Vinnova grant awarded to joint project between PolyPeptide and Red Glead Discovery for developing a more sustainable manufacturing method for a GLP-1 agonist.
27 Aug 2024 - PolyPeptide in Limhamn, Sweden and Red Glead Discovery in Lund, Sweden have joined forces to pursue the development of a more sustainable manufacturing method for a […]
Read more